AAN: Prophylactic Zonisamide Effective in Pediatric Migraine
Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups
RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public...
Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department
Epidural Steroid Injections Reviewed for Radicular Pain, Spinal Stenosis
Some evidence seen for ESIs reducing pain and disability in cervical and lumbar radiculopathies and possibly in lumbar spinal stenosis
Traumatic Experiences Associated With Endometriosis
Strongest associations seen for contact, emotional, physical, and sexual traumas
Pain Linked to Increased Odds of Cigarette, Cannabis Use in Cancer Survivors
Pain intensity linked to increased likelihood of using cigarettes, e-cigarettes, cannabis, lower likelihood of alcohol use
Opioid Rx in the ED Slightly Raises Risk for Future Opioid Use, Hospitalization
Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use
ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine
Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings
Number of Anesthesiology Residents Applying to Pain Medicine Fellowships Decreasing
45 percent decline reported in anesthesia-based applicants to pain medicine fellowships, with downward trend continuing in 2024
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence
